The role of amino acid transporters in inherited and acquired diseases.

Amino acids are essential building blocks of all mammalian cells. In addition to their role in protein synthesis, amino acids play an important role as energy fuels, precursors for a variety of metabolites and as signalling molecules. Disorders associated with the malfunction of amino acid transporters reflect the variety of roles that they fulfil in human physiology. Mutations of brain amino acid transporters affect neuronal excitability. Mutations of renal and intestinal amino acid transporters affect whole-body homoeostasis, resulting in malabsorption and renal problems. Amino acid transporters that are integral parts of metabolic pathways reduce the function of these pathways. Finally, amino acid uptake is essential for cell growth, thereby explaining their role in tumour progression. The present review summarizes the involvement of amino acid transporters in these roles as illustrated by diseases resulting from transporter malfunction.

[1]  R. Vandenberg,et al.  Loss-of-function mutations in the glutamate transporter SLC1A1 cause human dicarboxylic aminoaciduria. , 2011, The Journal of clinical investigation.

[2]  D. Meredith,et al.  SLC36A4 (hPAT4) Is a High Affinity Amino Acid Transporter When Expressed in Xenopus laevis Oocytes* , 2010, The Journal of Biological Chemistry.

[3]  E. Levtchenko,et al.  The pathogenesis of cystinosis: mechanisms beyond cystine accumulation. , 2010, American journal of physiology. Renal physiology.

[4]  D. Goberdhan,et al.  Proton-assisted amino-acid transporters are conserved regulators of proliferation and amino-acid-dependent mTORC1 activation , 2010, Oncogene.

[5]  D. Goldfarb,et al.  Pathophysiology and treatment of cystinuria , 2010, Nature Reviews Nephrology.

[6]  D. Lehotay,et al.  Diagnosis and high incidence of hyperornithinemia-hyperammonemia-homocitrullinemia (HHH) syndrome in northern Saskatchewan , 2010, Journal of Inherited Metabolic Disease.

[7]  S. Bröer,et al.  Renal imino acid and glycine transport system ontogeny and involvement in developmental iminoglycinuria. , 2010, The Biochemical journal.

[8]  Hannes Stockinger,et al.  Cancer-related issues of CD147. , 2010, Cancer genomics & proteomics.

[9]  J. Buxbaum,et al.  Slc25a12 Disruption Alters Myelination and Neurofilaments: A Model for a Hypomyelination Syndrome and Childhood Neurodevelopmental Disorders , 2010, Biological Psychiatry.

[10]  S. Rauch,et al.  A screen of SLC1A1 for OCD‐related alleles , 2010, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[11]  Yigong Shi,et al.  Mechanism of substrate recognition and transport by an amino acid antiporter , 2010, Nature.

[12]  B. Aouizerate,et al.  The glutamate-based genetic immune hypothesis in obsessive-compulsive disorder. An integrative approach from genes to symptoms , 2010, Neuroscience.

[13]  T. Saheki,et al.  Conventional diet therapy for hyperammonemia is risky in the treatment of hepatic encephalopathy associated with citrin deficiency. , 2010, Internal medicine.

[14]  N. Reyes,et al.  Transport mechanism of a bacterial homologue of glutamate transporters , 2009, Nature.

[15]  F. Sterky,et al.  AGC1 deficiency associated with global cerebral hypomyelination. , 2009, The New England journal of medicine.

[16]  Marek Gabriško,et al.  Looking for the ancestry of the heavy‐chain subunits of heteromeric amino acid transporters rBAT and 4F2hc within the GH13 α‐amylase family , 2009, The FEBS journal.

[17]  M. Ginsberg,et al.  Dependence of proliferative vascular smooth muscle cells on CD98hc (4F2hc, SLC3A2) , 2009, The Journal of experimental medicine.

[18]  E. Gouaux,et al.  Structure and Mechanism of a Na+-Independent Amino Acid Transporter , 2009, Science.

[19]  A. Munnich,et al.  Mutations in the mitochondrial glutamate carrier SLC25A22 in neonatal epileptic encephalopathy with suppression bursts , 2009, Clinical genetics.

[20]  A. Bröer,et al.  Mutation of Asparagine 76 in the Center of Glutamine Transporter SNAT3 Modulates Substrate-induced Conductances and Na+ Binding* , 2009, The Journal of Biological Chemistry.

[21]  H. Jayaram,et al.  Structure of a Prokaryotic Virtual Proton Pump at 3.2 Å Resolution , 2009, Nature.

[22]  Philippe Froguel,et al.  The genetic contribution to non-syndromic human obesity , 2009, Nature Reviews Genetics.

[23]  Yigong Shi,et al.  Structure and Mechanism of an Amino Acid Antiporter , 2009, Science.

[24]  T. Saheki,et al.  Neonatal intrahepatic cholestasis caused by citrin deficiency (NICCD) as a cause of liver disease in infants in the UK , 2009, Journal of Inherited Metabolic Disease.

[25]  M. Caron,et al.  Orphan Transporter SLC6A18 Is Renal Neutral Amino Acid Transporter B0AT3* , 2009, The Journal of Biological Chemistry.

[26]  S. Bröer.  The role of the neutral amino acid transporter B0AT1 (SLC6A19) in Hartnup disorder and protein nutrition , 2009, IUBMB life.

[27]  Harini Krishnamurthy,et al.  Unlocking the molecular secrets of sodium-coupled transporters , 2009, Nature.

[28]  M. Baumgartner,et al.  Identification of novel mutations in the SLC25A15 gene in hyperornithinemia‐hyperammonemia‐homocitrullinuria (HHH) syndrome: A clinical, molecular, and functional study , 2009, Human mutation.

[29]  R. Ruivo,et al.  Molecular and cellular basis of lysosomal transmembrane protein dysfunction. , 2009, Biochimica et biophysica acta.

[30]  D. Bu,et al.  A novel missense mutation in the SLC6A19 gene in a Chinese family with Hartnup disorder , 2009, International journal of dermatology.

[31]  Raphael Ruppert,et al.  CD98hc facilitates B cell proliferation and adaptive humoral immunity , 2009, Nature Immunology.

[32]  Jeffrey P. MacKeigan,et al.  Bidirectional Transport of Amino Acids Regulates mTOR and Autophagy , 2009, Cell.

[33]  G. Matthijs,et al.  Deletion of C2orf34, PREPL and SLC3A1 causes atypical hypotonia–cystinuria syndrome , 2009, BMJ Case Reports.

[34]  S. Takamori,et al.  A chloride conductance in VGLUT1 underlies maximal glutamate loading into synaptic vesicles , 2009, Nature Neuroscience.

[35]  A. Bröer,et al.  Sodium translocation by the iminoglycinuria associated imino transporter (SLC6A20) , 2009, Molecular membrane biology.

[36]  Robert Kleta,et al.  Tissue-Specific Amino Acid Transporter Partners ACE2 and Collectrin Differentially Interact With Hartnup Mutations , 2008, Gastroenterology.

[37]  R. Baloh,et al.  Episodic ataxia associated with EAAT1 mutation C186S affecting glutamate reuptake. , 2009, Archives of neurology.

[38]  N. Sunaga,et al.  l‐type amino acid transporter 1 and CD98 expression in primary and metastatic sites of human neoplasms , 2008, Cancer science.

[39]  S. Bröer,et al.  Iminoglycinuria and hyperglycinuria are discrete human phenotypes resulting from complex mutations in proline and glycine transporters. , 2008, The Journal of clinical investigation.

[40]  D. Torrents,et al.  Projection Structure of a Member of the Amino Acid/Polyamine/Organocation Transporter Superfamily* , 2008, Journal of Biological Chemistry.

[41]  Catherine Overy,et al.  The mechanism of transport by mitochondrial carriers based on analysis of symmetry , 2008, Proceedings of the National Academy of Sciences.

[42]  R. Drouin,et al.  Phenotypic variability among patients with hyperornithinaemia–hyperammonaemia–homocitrullinuria syndrome homozygous for the delF188 mutation in SLC25A15 , 2008, Journal of Medical Genetics.

[43]  I. Chu,et al.  Minisatellite polymorphisms of the SLC6A19: susceptibility in hypertension. , 2008, Biochemical and biophysical research communications.

[44]  Jeonghoon Heo,et al.  Analysis of VNTRs in the solute carrier family 6, member 18 (SLC6A18) and lack of association with hypertension. , 2008, DNA and cell biology.

[45]  M. Topf,et al.  The genetics of hyperekplexia: more than startle! , 2008, Trends in genetics : TIG.

[46]  R. Bellone,et al.  Missense Mutation in Exon 2 of SLC36A1 Responsible for Champagne Dilution in Horses , 2008, PLoS genetics.

[47]  B. Giros,et al.  Impairment of SLC17A8 encoding vesicular glutamate transporter-3, VGLUT3, underlies nonsyndromic deafness DFNA25 and inner hair cell dysfunction in null mice. , 2008, American journal of human genetics.

[48]  J. Rasko,et al.  A protein complex in the brush‐border membrane explains a Hartnup disorder allele , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[49]  Ferdinando Palmieri,et al.  Diseases caused by defects of mitochondrial carriers: a review. , 2008, Biochimica et biophysica acta.

[50]  M. Palacín,et al.  Distinct classes of trafficking rBAT mutants cause the type I cystinuria phenotype. , 2008, Human molecular genetics.

[51]  M. Ginsberg,et al.  Integrin‐associated proteins as potential therapeutic targets , 2008, Immunological reviews.

[52]  B. Turk,et al.  AMPK phosphorylation of raptor mediates a metabolic checkpoint. , 2008, Molecular cell.

[53]  H. Sitte,et al.  Glycine Transporter Dimers , 2008, Journal of Biological Chemistry.

[54]  T. Saheki,et al.  Reduced carbohydrate intake in citrin-deficient subjects , 2008, Journal of Inherited Metabolic Disease.

[55]  T. Saheki,et al.  Identification of 13 novel mutations including a retrotransposal insertion in SLC25A13 gene and frequency of 30 mutations found in patients with citrin deficiency , 2008, Journal of Human Genetics.

[56]  A. Chaudhuri,et al.  An adult with type 2 citrullinemia presenting in Europe. , 2008, The New England journal of medicine.

[57]  Eunyoung Yi,et al.  Sensorineural Deafness and Seizures in Mice Lacking Vesicular Glutamate Transporter 3 , 2008, Neuron.

[58]  M. P. Sperandeo,et al.  Lysinuric protein intolerance: update and extended mutation analysis of the SLC7A7 gene , 2008, Human mutation.

[59]  S. Bröer,et al.  Amino acid transport across mammalian intestinal and renal epithelia. , 2008, Physiological reviews.

[60]  M. Orozco,et al.  The Structure of Human 4F2hc Ectodomain Provides a Model for Homodimerization and Electrostatic Interaction with Plasma Membrane* , 2007, Journal of Biological Chemistry.

[61]  Jonathan A. Javitch,et al.  Mechanism of chloride interaction with neurotransmitter:sodium symporters , 2007, Nature.

[62]  L. Looger,et al.  Nanosensor Detection of an Immunoregulatory Tryptophan Influx/Kynurenine Efflux Cycle , 2007, PLoS biology.

[63]  Keiko Kobayashi,et al.  Citrin/Mitochondrial Glycerol-3-phosphate Dehydrogenase Double Knock-out Mice Recapitulate Features of Human Citrin Deficiency* , 2007, Journal of Biological Chemistry.

[64]  Barry Honig,et al.  Identification of a chloride ion binding site in Na+/Cl−-dependent transporters , 2007, Proceedings of the National Academy of Sciences.

[65]  R. Finger,et al.  ASCT2 silencing regulates mammalian target-of-rapamycin growth and survival signaling in human hepatoma cells. , 2007, American journal of physiology. Cell physiology.

[66]  G. Borsani,et al.  Slc7a7 disruption causes fetal growth retardation by downregulating Igf1 in the mouse model of lysinuric protein intolerance. , 2007, American journal of physiology. Cell physiology.

[67]  Raoul Rooman,et al.  Global distribution of the most prevalent deletions causing hypotonia–cystinuria syndrome , 2007, European Journal of Human Genetics.

[68]  K. Zerres,et al.  Isolated cystinuria (OMIM 238200) is not a separate entity but is caused by a mutation in the cystinuria gene SLC7A9 , 2007, Clinical genetics.

[69]  M. Birnbaum,et al.  The Role of AMPK and mTOR in Nutrient Sensing in Pancreatic β-Cells* , 2007, Journal of Biological Chemistry.

[70]  D. Olivieri,et al.  Alveolar macrophages from normal subjects lack the NOS-related system y+ for arginine transport. , 2007, American journal of respiratory cell and molecular biology.

[71]  T. Saheki,et al.  Citrin Deficiency: A Novel Cause of Failure to Thrive That Responds to a High-Protein, Low-Carbohydrate Diet , 2007, Pediatrics.

[72]  T. Saheki,et al.  Clinical pictures of 75 patients with neonatal intrahepatic cholestasis caused by citrin deficiency (NICCD) , 2007, Journal of Inherited Metabolic Disease.

[73]  D. Thwaites,et al.  Deciphering the mechanisms of intestinal imino (and amino) acid transport: the redemption of SLC36A1. , 2007, Biochimica et biophysica acta.

[74]  J. Penninger,et al.  Essential role for collectrin in renal amino acid transport , 2006, Nature.

[75]  T. Hosoyamada.  [Clinical studies of pediatric malabsorption syndromes]. , 2006, Fukuoka igaku zasshi = Hukuoka acta medica.

[76]  S. Cederbaum,et al.  Clinical and Functional Characterization of a Human ORNT1 Mutation (T32R) in the Hyperornithinemia-Hyperammonemia-Homocitrullinuria (HHH) Syndrome , 2006, Pediatric Research.

[77]  M. Palacín,et al.  The Structural and Functional Units of Heteromeric Amino Acid Transporters , 2006, Journal of Biological Chemistry.

[78]  I. Georgiou,et al.  Evidence for association of SLC7A9 gene haplotypes with cystinuria manifestation in SLC7A9 mutation carriers , 2006, Urological Research.

[79]  S. Bröer.  The SLC6 orphans are forming a family of amino acid transporters , 2006, Neurochemistry International.

[80]  Y. Kanai,et al.  A novel missense mutation of SLC7A9 frequent in Japanese cystinuria cases affecting the C-terminus of the transporter. , 2006, Kidney international.

[81]  福井 健司.  The HNF-1 target Collectrin controls insulin exocytosis by SNARE complex formation , 2006 .

[82]  Anita Shah,et al.  System B0,+ amino acid transport regulates the penetration stage of blastocyst implantation with possible long-term developmental consequences through adulthood. , 2006, Human reproduction update.

[83]  M. Hall,et al.  TOR Signaling in Growth and Metabolism , 2006, Cell.

[84]  A. Robinson,et al.  Mitochondrial carriers in the cytoplasmic state have a common substrate binding site. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[85]  F. Santorelli,et al.  HHH syndrome (hyperornithinaemia, hyperammonaemia, homocitrullinuria), with fulminant hepatitis-like presentation , 2006, Journal of Inherited Metabolic Disease.

[86]  H. Betz,et al.  Glycine transporters: essential regulators of synaptic transmission. , 2006, Biochemical Society transactions.

[87]  Claude Bouchard,et al.  The Human Obesity Gene Map: The 2005 Update , 2006, Obesity.

[88]  A. Koizumi,et al.  A nonsense polymorphism (Y319X) of the solute carrier family 6 member 18 (SLC6A18) gene is not associated with hypertension and blood pressure in Japanese. , 2006, The Tohoku journal of experimental medicine.

[89]  F. de Zegher,et al.  Deletion of PREPL, a gene encoding a putative serine oligopeptidase, in patients with hypotonia-cystinuria syndrome. , 2006, American journal of human genetics.

[90]  M. Owen,et al.  Mutations in the gene encoding GlyT2 (SLC6A5) define a presynaptic component of human startle disease , 2006, Nature Genetics.

[91]  R. Swanson,et al.  Neuronal glutathione deficiency and age-dependent neurodegeneration in the EAAC1 deficient mouse , 2006, Nature Neuroscience.

[92]  T. Saheki,et al.  Metabolic derangements in deficiency of citrin, a liver-type mitochondrial aspartate-glutamate carrier. , 2005, Hepatology research : the official journal of the Japan Society of Hepatology.

[93]  D. Morioka,et al.  Living Donor Liver Transplantation for Noncirrhotic Inheritable Metabolic Liver Diseases: Impact of the Use of Heterozygous Donors , 2005, Transplantation.

[94]  Eric Gouaux,et al.  Crystal structure of a bacterial homologue of Na+/Cl--dependent neurotransmitter transporters , 2005, Nature.

[95]  T. Saheki,et al.  Reduced N-Acetylaspartate Levels in Mice Lacking Aralar, a Brain- and Muscle-type Mitochondrial Aspartate-glutamate Carrier* , 2005, Journal of Biological Chemistry.

[96]  R. Baloh,et al.  Mutation in the glutamate transporter EAAT1 causes episodic ataxia, hemiplegia, and seizures , 2005, Neurology.

[97]  M. Hemler,et al.  Metabolic Activation-related CD147-CD98 Complex*S , 2005, Molecular & Cellular Proteomics.

[98]  B. Fuchs,et al.  Amino acid transporters ASCT2 and LAT1 in cancer: partners in crime? , 2005, Seminars in cancer biology.

[99]  A. Bröer,et al.  Characterization of mouse amino acid transporter B0AT1 (slc6a19). , 2005, The Biochemical journal.

[100]  Dong Hwan Lee,et al.  Frequency and distribution in East Asia of 12 mutations identified in the SLC25A13 gene of Japanese patients with citrin deficiency , 2005, Journal of Human Genetics.

[101]  D. Meredith,et al.  PAT-related amino acid transporters regulate growth via a novel mechanism that does not require bulk transport of amino acids , 2005, Development.

[102]  M. P. Sperandeo,et al.  A y+LAT-1 mutant protein interferes with y+LAT-2 activity: implications for the molecular pathogenesis of lysinuric protein intolerance , 2005, European Journal of Human Genetics.

[103]  M. P. Sperandeo,et al.  Lysinuric protein intolerance: identification and functional analysis of mutations of the SLC7A7 gene , 2005, Human mutation.

[104]  H. Daniel,et al.  Kinetics of bidirectional H+ and substrate transport by the proton-dependent amino acid symporter PAT1. , 2005, The Biochemical journal.

[105]  S. Bröer,et al.  Molecular cloning of the mouse IMINO system: an Na+- and Cl--dependent proline transporter. , 2005, The Biochemical journal.

[106]  A. Munnich,et al.  Impaired mitochondrial glutamate transport in autosomal recessive neonatal myoclonic epilepsy. , 2005, American journal of human genetics.

[107]  H. Stuhlmann,et al.  CD98hc (SLC3A2) mediates integrin signaling. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[108]  M. Palacín,et al.  New insights into cystinuria: 40 new mutations, genotype–phenotype correlation, and digenic inheritance causing partial phenotype , 2005, Journal of Medical Genetics.

[109]  D. Shapcott,et al.  Newborn urine screening experience with over one million infants in the Quebec Network of Genetic Medicine , 1988, Journal of Inherited Metabolic Disease.

[110]  B. Munck,et al.  Lysine transport across the small intestine. Stimulating and inhibitory effects of neutral amino acids , 1980, The Journal of Membrane Biology.

[111]  B. G. Munck.  Transport of neutral and cationic amino acids across the brush-border membrane of the rabbit ileum , 2005, The Journal of Membrane Biology.

[112]  C. Haslett,et al.  CD98hc (SLC3A2) Interaction with β1 Integrins Is Required for Transformation* , 2004, Journal of Biological Chemistry.

[113]  P. M. Taylor,et al.  H+/amino acid transporter 1 (PAT1) is the imino acid carrier: An intestinal nutrient/drug transporter in human and rat. , 2004, Gastroenterology.

[114]  E. Gouaux,et al.  Structure of a glutamate transporter homologue from Pyrococcus horikoshii , 2004, Nature.

[115]  V. Willour,et al.  Replication study supports evidence for linkage to 9p24 in obsessive-compulsive disorder. , 2004, American journal of human genetics.

[116]  Philippe Froguel,et al.  Polymorphisms in the amino acid transporter solute carrier family 6 (neurotransmitter transporter) member 14 gene contribute to polygenic obesity in French Caucasians. , 2004, Diabetes.

[117]  W. Gahl,et al.  Mutations in SLC6A19, encoding B0AT1, cause Hartnup disorder , 2004, Nature Genetics.

[118]  A. Bröer,et al.  Hartnup disorder is caused by mutations in the gene encoding the neutral amino acid transporter SLC6A19 , 2004, Nature Genetics.

[119]  M. Palacín,et al.  Membrane Topology of System Xc- Light Subunit Reveals a Re-entrant Loop with Substrate-restricted Accessibility* , 2004, Journal of Biological Chemistry.

[120]  S. Bröer,et al.  Molecular Cloning of Mouse Amino Acid Transport System B0, a Neutral Amino Acid Transporter Related to Hartnup Disorder* , 2004, Journal of Biological Chemistry.

[121]  W. Wetsel,et al.  Hypertension and Impaired Glycine Handling in Mice Lacking the Orphan Transporter XT2 , 2004, Molecular and Cellular Biology.

[122]  Nigel M Hooper,et al.  ACE2: from vasopeptidase to SARS virus receptor , 2004, Trends in Pharmacological Sciences.

[123]  K. Hsiao,et al.  Adult-onset type II citrullinemia and idiopathic neonatal hepatitis caused by citrin deficiency: involvement of the aspartate glutamate carrier for urea synthesis and maintenance of the urea cycle. , 2004, Molecular genetics and metabolism.

[124]  M. Palacín,et al.  Lysinuric protein intolerance: mechanisms of pathophysiology. , 2004, Molecular genetics and metabolism.

[125]  R. Ledeen,et al.  N-Acetylaspartate synthase is bimodally expressed in microsomes and mitochondria of brain. , 2004, Brain research. Molecular brain research.

[126]  Ferdinando Palmieri,et al.  The mitochondrial transporter family (SLC25): physiological and pathological implications , 2004, Pflügers Archiv.

[127]  R. Reimer,et al.  Organic anion transport is the primary function of the SLC17/type I phosphate transporter family , 2004, Pflügers Archiv.

[128]  M. Palacín,et al.  CATs and HATs: the SLC7 family of amino acid transporters , 2004, Pflügers Archiv.

[129]  M. Palacín,et al.  The ancillary proteins of HATs: SLC3 family of amino acid transporters , 2004, Pflügers Archiv.

[130]  D. Meredith,et al.  The SLC16 gene family—from monocarboxylate transporters (MCTs) to aromatic amino acid transporters and beyond , 2004, Pflügers Archiv.

[131]  L. Tsui,et al.  Slc25a13-Knockout Mice Harbor Metabolic Deficits but Fail To Display Hallmarks of Adult-Onset Type II Citrullinemia , 2004, Molecular and Cellular Biology.

[132]  C. Scriver,et al.  The Metabolic and Molecular Bases of Inherited Disease, 8th Edition 2001 , 2001, Journal of Inherited Metabolic Disease.

[133]  P. P. Reddy,et al.  Dicarboxylic aminoaciduria associated with mental retardation , 1989, Human Genetics.

[134]  T. Rauen,et al.  Electrogenic Glutamate Transporters in the CNS: Molecular Mechanism, Pre-steady-state Kinetics, and their Impact on Synaptic Signaling , 2004, The Journal of Membrane Biology.

[135]  Kaisa Silander,et al.  The SLC6A14 gene shows evidence of association with obesity. , 2003, The Journal of clinical investigation.

[136]  Eva Pebay-Peyroula,et al.  Structure of mitochondrial ADP/ATP carrier in complex with carboxyatractyloside , 2003, Nature.

[137]  M. Hediger,et al.  The glutamate and neutral amino acid transporter family: physiological and pharmacological implications. , 2003, European journal of pharmacology.

[138]  M. Tsurudome,et al.  The targeted disruption of the CD98 gene results in embryonic lethality. , 2003, Biochemical and biophysical research communications.

[139]  M. Palacín,et al.  Slc7a9-deficient mice develop cystinuria non-I and cystine urolithiasis. , 2003, Human molecular genetics.

[140]  M. Nehls,et al.  A mouse model for cystinuria type I. , 2003, Human molecular genetics.

[141]  John E. Walker,et al.  The Mitochondrial Ornithine Transporter , 2003, Journal of Biological Chemistry.

[142]  N. Rioseco-Camacho,et al.  Cloning and characterization of human ORNT2: a second mitochondrial ornithine transporter that can rescue a defective ORNT1 in patients with the hyperornithinemia-hyperammonemia-homocitrullinuria syndrome, a urea cycle disorder. , 2003, Molecular genetics and metabolism.

[143]  Keiko Kobayashi,et al.  Developmental changes in the Ca2+-regulated mitochondrial aspartate-glutamate carrier aralar1 in brain and prominent expression in the spinal cord. , 2003, Brain research. Developmental brain research.

[144]  K. Zerres,et al.  Genetic variations of the SLC7A9 gene: allele distribution of 13 polymorphic sites in German cystinuria patients and controls. , 2003, Clinical nephrology.

[145]  T. Saheki,et al.  Effectiveness of carbohydrate-restricted diet and arginine granules therapy for adult-onset type II citrullinemia: a case report of siblings showing homozygous SLC25A13 mutation with and without the disease. , 2003, Hepatology research : the official journal of the Japan Society of Hepatology.

[146]  F. Verrey,et al.  Functional Cooperation of Epithelial Heteromeric Amino Acid Transporters Expressed in Madin-Darby Canine Kidney Cells* , 2003, The Journal of Biological Chemistry.

[147]  P. Söderkvist,et al.  Mutation analysis of SLC7A9 in cystinuria patients in Sweden. , 2003, Genetic testing.

[148]  K. Ihara,et al.  Five novel SLC7A7 variants and y+L gene‐expression pattern in cultured lymphoblasts from Japanese patients with lysinuric protein intolerance , 2002, Human Mutation.

[149]  C. Antignac,et al.  Cystinosis: from gene to disease. , 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[150]  D. Copenhagen,et al.  The identification of vesicular glutamate transporter 3 suggests novel modes of signaling by glutamate , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[151]  M. Roux,et al.  Why glycine transporters have different stoichiometries , 2002, FEBS letters.

[152]  M. Gallucci,et al.  Comparison between SLC3A1 and SLC7A9 cystinuria patients and carriers: a need for a new classification. , 2002, Journal of the American Society of Nephrology : JASN.

[153]  M. Palacín,et al.  The light subunit of system bo,+ is fully functional in the absence of the heavy subunit , 2002, The EMBO journal.

[154]  R. Rintoul,et al.  Cross-linking CD98 promotes integrin-like signaling and anchorage-independent growth. , 2002, Molecular biology of the cell.

[155]  B. Leventhal,et al.  Genome-wide linkage analysis of families with obsessive-compulsive disorder ascertained through pediatric probands. , 2002, American journal of medical genetics.

[156]  H. Daniel,et al.  Functional Characterization of Two Novel Mammalian Electrogenic Proton-dependent Amino Acid Cotransporters* , 2002, The Journal of Biological Chemistry.

[157]  V. Balcar.  Molecular pharmacology of the Na+-dependent transport of acidic amino acids in the mammalian central nervous system. , 2002, Biological & pharmaceutical bulletin.

[158]  C. Meier,et al.  Activation of system L heterodimeric amino acid exchangers by intracellular substrates , 2002, The EMBO journal.

[159]  S. Salvi,et al.  Seven novel mutations in the ORNT1 gene (SLC25A15) in patients with hyperornithinemia, hyperammonemia, and homocitrullinuria syndrome , 2001, Human mutation.

[160]  C. Antignac,et al.  Cystinosin, the protein defective in cystinosis, is a H+‐driven lysosomal cystine transporter , 2001, The EMBO journal.

[161]  T. V. Kolesnikova,et al.  β1 integrins show specific association with CD98 protein in low density membranes , 2001, BMC Biochemistry.

[162]  Y. Kanai,et al.  Human L-type amino acid transporter 1 (LAT1): characterization of function and expression in tumor cell lines. , 2001, Biochimica et biophysica acta.

[163]  D. Landau,et al.  A recessive contiguous gene deletion of chromosome 2p16 associated with cystinuria and a mitochondrial disease. , 2001, American journal of human genetics.

[164]  N. Danbolt.  Glutamate uptake , 2001, Progress in Neurobiology.

[165]  T. Saheki,et al.  Citrin and aralar1 are Ca2+‐stimulated aspartate/glutamate transporters in mitochondria , 2001, The EMBO journal.

[166]  R. Ledeen,et al.  Intraneuronal N‐acetylaspartate supplies acetyl groups for myelin lipid synthesis: evidence for myelin‐associated aspartoacylase , 2001, Journal of neurochemistry.

[167]  B. Giros,et al.  Identification and characterization of a lysosomal transporter for small neutral amino acids , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[168]  G. Borsani,et al.  The molecular bases of cystinuria and lysinuric protein intolerance. , 2001, Current opinion in genetics & development.

[169]  T. Saheki,et al.  Pathogenesis of adult-onset type II citrullinemia caused by deficiency of citrin, a mitochondrial solute carrier protein: tissue and subcellular localization of citrin. , 2001, Advances in enzyme regulation.

[170]  S. Tsujino,et al.  Diagnosis of Japanese patients with HHH syndrome by molecular genetic analysis: a common mutation, R179X , 2001, Journal of Human Genetics.

[171]  V. Ganapathy,et al.  Na+- and Cl--coupled active transport of carnitine by the amino acid transporter ATB(0,+) from mouse colon expressed in HRPE cells and Xenopus oocytes. , 2001, The Journal of physiology.

[172]  M. Ginsberg,et al.  Distinct Domains of CD98hc Regulate Integrins and Amino Acid Transport* , 2001, The Journal of Biological Chemistry.

[173]  X. Estivill,et al.  Functional analysis of mutations in SLC7A9, and genotype-phenotype correlation in non-Type I cystinuria. , 2001, Human molecular genetics.

[174]  T. Saheki,et al.  Neonatal presentation of adult-onset type II citrullinemia , 2001, Human Genetics.

[175]  M. P. Sperandeo,et al.  Arginine transport through system y(+)L in cultured human fibroblasts: normal phenotype of cells from LPI subjects. , 2000, American journal of physiology. Cell physiology.

[176]  Christian Rosenmund,et al.  Identification of a vesicular glutamate transporter that defines a glutamatergic phenotype in neurons , 2000, Nature.

[177]  L. Peltonen,et al.  Genome-wide scan of obesity in Finnish sibpairs reveals linkage to chromosome Xq24. , 2000, The Journal of clinical endocrinology and metabolism.

[178]  R. Fremeau,et al.  Uptake of glutamate into synaptic vesicles by an inorganic phosphate transporter. , 2000, Science.

[179]  A. Bröer,et al.  The heterodimeric amino acid transporter 4F2hc/y+LAT2 mediates arginine efflux in exchange with glutamine. , 2000, The Biochemical journal.

[180]  Y. Kanai,et al.  Transport Properties of a System y+L Neutral and Basic Amino Acid Transporter , 2000, The Journal of Biological Chemistry.

[181]  S. Bröer,et al.  Neutral amino acid transporter ASCT2 displays substrate-induced Na+ exchange and a substrate-gated anion conductance. , 2000, The Biochemical journal.

[182]  D. Torrents,et al.  Functional analysis of novel mutations in y(+)LAT-1 amino acid transporter gene causing lysinuric protein intolerance (LPI). , 2000, Human molecular genetics.

[183]  J. Satrústegui,et al.  Characterization of a second member of the subfamily of calcium-binding mitochondrial carriers expressed in human non-excitable tissues. , 2000, The Biochemical journal.

[184]  B. Greenberg,et al.  Altered cortical excitability in obsessive–compulsive disorder , 2000, Neurology.

[185]  C. Boyd,et al.  Cationic amino acid transport through system y+L in erythrocytes of patients with lysinuric protein intolerance , 2000, Pflügers Archiv.

[186]  A. Bröer,et al.  The Astroglial ASCT2 Amino Acid Transporter as a Mediator of Glutamine Efflux , 1999, Journal of neurochemistry.

[187]  X. Estivill,et al.  Non-type I cystinuria caused by mutations in SLC7A9, encoding a subunit (bo,+AT) of rBAT , 1999, Nature Genetics.

[188]  S. Mager,et al.  Cloning and Functional Expression of a Human Na+and Cl−-dependent Neutral and Cationic Amino Acid Transporter B0+ * , 1999, The Journal of Biological Chemistry.

[189]  S. Almashanu,et al.  Hyperornithinaemia-hyperammonaemia-homocitrullinuria syndrome is caused by mutations in a gene encoding a mitochondrial ornithine transporter , 1999, Nature Genetics.

[190]  D. Torrents,et al.  Identification of SLC7A7, encoding y+LAT-1, as the lysinuric protein intolerance gene , 1999, Nature Genetics.

[191]  G. Borsani,et al.  SLC7A7, encoding a putative permease-related protein, is mutated in patients with lysinuric protein intolerance , 1999, Nature Genetics.

[192]  L. Kühn,et al.  Amino acid transport of y+L‐type by heterodimers of 4F2hc/CD98 and members of the glycoprotein‐associated amino acid transporter family , 1999, The EMBO journal.

[193]  G. Borsani,et al.  is mutated in patients with lysinuric protein intolerance , 1999 .

[194]  S. Mager,et al.  Cloning and functional expression of a human Na(+) and Cl(-)-dependent neutral and cationic amino acid transporter B(0+). , 1999, The Journal of biological chemistry.

[195]  D. Torrents,et al.  Identification and Characterization of a Membrane Protein (y+L Amino Acid Transporter-1) That Associates with 4F2hc to Encode the Amino Acid Transport Activity y+L , 1998, The Journal of Biological Chemistry.

[196]  C. Shoemaker,et al.  Amino-acid transport by heterodimers of 4F2hc/CD98 and members of a permease family , 1998, Nature.

[197]  O. Gribouval,et al.  A novel gene encoding an integral membrane protein is mutated in nephropathic cystinosis , 1998, Nature Genetics.

[198]  M. Nagao,et al.  [Lysinuric protein intolerance and other cationic aminoacidurias]. , 1998, Ryoikibetsu shokogun shirizu.

[199]  S. Kawasaki,et al.  Complete neurological recovery of an adult patient with type II citrullinemia after living related partial liver transplantation. , 1996, Transplantation.

[200]  M. Kavanaugh,et al.  Flux coupling in a neuronal glutamate transporter , 1996, Nature.

[201]  J. Gelpí,et al.  Obligatory Amino Acid Exchange via Systems bo,+-like and y+L-like , 1996, The Journal of Biological Chemistry.

[202]  F. Lang,et al.  Opposite directed currents induced by the transport of dibasic and neutral amino acids in Xenopus oocytes expressing the protein rBAT. , 1994, The Journal of biological chemistry.

[203]  X. Estivill,et al.  Cystinuria caused by mutations in rBAT, a gene involved in the transport of cystine , 1994, Nature Genetics.

[204]  A. Beaudet,et al.  A search for the primary abnormality in adult-onset type II citrullinemia. , 1993, American journal of human genetics.

[205]  D. Milliner,et al.  Urolithiasis in pediatric patients. , 1993, Mayo Clinic proceedings.

[206]  M. Palacín,et al.  Expression cloning of a cDNA from rabbit kidney cortex that induces a single transport system for cystine and dibasic and neutral amino acids. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[207]  N. Herschkowitz,et al.  N-acetyl-L-aspartate is a major source of acetyl groups for lipid synthesis during rat brain development. , 1991, Developmental neuroscience.

[208]  H. Christensen,et al.  Role of amino acid transport and countertransport in nutrition and metabolism. , 1990, Physiological reviews.

[209]  N. Oppenheimer,et al.  Structure and mechanism , 1989 .

[210]  J. Hell,et al.  Glutamate uptake by brain synaptic vesicles. Energy dependence of transport and functional reconstitution in proteoliposomes. , 1988, The Journal of biological chemistry.

[211]  R. Kauppinen,et al.  Aminooxyacetic acid inhibits the malate-aspartate shuttle in isolated nerve terminals and prevents the mitochondria from utilizing glycolytic substrates. , 1987, Biochimica et biophysica acta.

[212]  C. Laberge,et al.  The Hartnup phenotype: Mendelian transport disorder, multifactorial disease. , 1987, American journal of human genetics.

[213]  D. Bender.  Biochemistry of tryptophan in health and disease. , 1983, Molecular aspects of medicine.

[214]  B. Wilcken,et al.  Urine screening for aminoacidopathies: is it beneficial? Results of a long-term follow-up of cases detected bny screening one millon babies. , 1980, The Journal of pediatrics.

[215]  O. Simell,et al.  BASOLATERAL-MEMBRANE TRANSPORT DEFECT FOR LYSINE IN LYSINURIC PROTEIN INTOLERANCE , 1980, The Lancet.

[216]  J. Perheentupa,et al.  Lysine fluxes across the jejunal epithelium in lysinuric protein intolerance. , 1980, The Journal of clinical investigation.

[217]  T. Patel,et al.  Synthesis of N-acetyl-L-aspartate by rat brain mitochondria and its involvement in mitochondrial/cytosolic carbon transport. , 1979, The Biochemical journal.

[218]  C. Owens,et al.  Amino acid transport , 1979, Nature.

[219]  B. Lemieux,et al.  Dicarboxylic aminoaciduria: an inborn error of amino acid conservation. , 1977, The Journal of pediatrics.

[220]  M. Giesberts,et al.  Dicarboxylic aminoaciduria: an inborn error of glutamate and aspartate transport with metabolic implications, in combination with a hyperprolinemia. , 1974, Metabolism: clinical and experimental.

[221]  L. Rosenberg,et al.  Familial hyperglycinuria. New defect in renal tubular transport of glycine and imino acids. , 1973, The American journal of medicine.

[222]  A. Lajtha,et al.  Amino Acid Transport , 1972 .

[223]  P. Procopis,et al.  Iminoaciduria: a benign renal tubular defect. , 1971, The Journal of pediatrics.

[224]  C R Scriver,et al.  Human genetics of membrane transport with emphasis on amino acids. , 1970, Advances in human genetics.

[225]  H. Moser,et al.  Hyperornithinemia, hyperammonemia, and homocitrullinuria. A new disorder of amino acid metabolism associated with myoclonic seizures and mental retardation. , 1969, American journal of diseases of children.

[226]  J. L. Durant,et al.  Intestinal absorption and renal extraction of cystine and cysteine in cystinuria. , 1965, The New England journal of medicine.

[227]  L. Rosenberg,et al.  CYSTINURIA: DEFECTIVE INTESTINAL TRANSPORT OF DIBASIC AMINO ACIDS AND CYSTINE. , 1965, The Journal of clinical investigation.

[228]  L. Rosenberg,et al.  Cystinuria: In vitro Demonstration of an Intestinal Transport Defect , 1964, Science.

[229]  H. Harris,et al.  Hereditary pellagra-like skin rash with temporary cerebellar ataxia, constant renal amino-aciduria, and other bizarre biochemical features. , 1956, Lancet.

[230]  Neha Garg,et al.  Living donor liver , 2022 .